Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Moves Into Japan with Daiichi Deal

NEW YORK, July 8-Daiichi Pharmaceuticals has arranged a nonexclusive subscription to Inpharmatica's Biopendium protein database, Inpharmatica said yesterday.


The specific financial conditions of the agreement were not disclosed.


Biopendium includes protein sequences and structures, as well as tools to predict protein/ligand interactions and compare sequence patterns. It is designed for target discovery and lead compound identification.


Daiichi is Inpharmatica's first Japanese client, joining subscribers such as Pfizer and Genentech.


Inpharmatica is based in London.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.